CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
44.36
+0.58 (1.32%)
At close: Dec 20, 2024, 4:00 PM
44.40
+0.04 (0.09%)
After-hours: Dec 20, 2024, 7:56 PM EST
CVS Health Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for CVS Health stock have an average target of 71.12, with a low estimate of 58 and a high estimate of 94. The average target predicts an increase of 60.32% from the current stock price of 44.36.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CVS Health stock from 17 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 7 |
| Buy | 8 | 6 | 5 | 7 | 7 | 7 |
| Hold | 7 | 7 | 7 | 5 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 19 | 18 | 18 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades $66 | Hold → Strong Buy | Upgrades | $66 | +48.78% | Dec 3, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $73 → $80 | Strong Buy | Maintains | $73 → $80 | +80.34% | Nov 25, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $72 → $64 | Buy | Maintains | $72 → $64 | +44.27% | Nov 25, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $76 → $67 | Strong Buy | Reiterates | $76 → $67 | +51.04% | Nov 20, 2024 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $60 → $66 | Hold → Buy | Upgrades | $60 → $66 | +48.78% | Nov 18, 2024 |
Financial Forecast
Revenue This Year
375.97B
from 356.62B
Increased by 5.42%
Revenue Next Year
391.74B
from 375.97B
Increased by 4.19%
EPS This Year
5.32
from 6.47
Decreased by -17.82%
EPS Next Year
6.21
from 5.32
Increased by 16.72%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 394.0B | 422.6B | 455.9B | |||
| Avg | 376.0B | 391.7B | 411.6B | |||
| Low | 360.7B | 363.1B | 371.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 10.5% | 12.4% | 16.4% | |||
| Avg | 5.4% | 4.2% | 5.1% | |||
| Low | 1.1% | -3.4% | -5.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 6.11 | 7.86 | 8.46 | |||
| Avg | 5.32 | 6.21 | 7.15 | |||
| Low | 4.59 | 5.15 | 5.90 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -5.5% | 47.9% | 36.4% | |||
| Avg | -17.8% | 16.7% | 15.3% | |||
| Low | -29.1% | -3.1% | -4.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.